tiprankstipranks
Trending News
More News >
KYORIN Pharmaceutical Co.,Ltd. (JP:4569)
:4569
Japanese Market

KYORIN Pharmaceutical Co.,Ltd. (4569) Financial Statements

Compare
2 Followers

KYORIN Pharmaceutical Co.,Ltd. Financial Overview

KYORIN Pharmaceutical Co.,Ltd.'s market cap is currently ¥78.96B. The company's EPS TTM is ¥115.71; its P/E ratio is 9.48; and it has a dividend yield of 0.67%. KYORIN Pharmaceutical Co.,Ltd. is scheduled to report earnings on May 12, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 130.09B¥ 119.53B¥ 113.27B¥ 105.53B¥ 102.90B
Gross Profit¥ 59.51B¥ 51.41B¥ 50.17B¥ 49.44B¥ 51.63B
Operating Income¥ 12.55B¥ 6.01B¥ 5.12B¥ 5.01B¥ 5.79B
EBITDA¥ 17.55B¥ 11.37B¥ 8.96B¥ 8.72B¥ 9.34B
Net Income¥ 9.09B¥ 5.32B¥ 4.72B¥ 3.93B¥ 6.13B
Balance Sheet
Cash & Short-Term Investments¥ 16.51B¥ 13.98B¥ 19.39B¥ 27.49B¥ 30.84B
Total Assets¥ 193.62B¥ 177.68B¥ 176.04B¥ 171.92B¥ 167.13B
Total Debt¥ 28.44B¥ 20.95B¥ 21.28B¥ 21.62B¥ 21.88B
Net Debt¥ 13.42B¥ 7.06B¥ 1.88B¥ -5.37B¥ -5.56B
Total Liabilities¥ 57.33B¥ 46.90B¥ 50.59B¥ 47.42B¥ 42.47B
Stockholders' Equity¥ 136.28B¥ 130.78B¥ 125.46B¥ 124.51B¥ 124.66B
Cash Flow
Free Cash Flow¥ -2.19B¥ -4.70B¥ -7.40B¥ 3.66B¥ 65.00M
Operating Cash Flow¥ 3.51B¥ 1.55B¥ 2.01B¥ 6.35B¥ 5.19B
Investing Cash Flow¥ -6.32B¥ -3.19B¥ -6.28B¥ -2.56B¥ -4.26B
Financing Cash Flow¥ 3.95B¥ -3.35B¥ -3.36B¥ -4.11B¥ -4.92B
Currency in JPY

KYORIN Pharmaceutical Co.,Ltd. Earnings and Revenue History

KYORIN Pharmaceutical Co.,Ltd. Debt to Assets

KYORIN Pharmaceutical Co.,Ltd. Cash Flow

KYORIN Pharmaceutical Co.,Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis